AI Summary
The FDA has concerns about an experimental stem cell therapy for ALS that will be discussed at a public hearing.
The FDA has raised concerns about the safety and efficacy of an experimental stem cell therapy for ALS scheduled for a public hearing by a federal advisory panel on Wednesday.
Medscape Medical News